Skip to main content

Examining a Vaccine for One of the Top 10 Global Health Threats

May 22, 2020

phpDengue is the fastest spreading mosquito-borne viral disease and was recently designated as one of the World Health Organization’s top 10 threats to global health. Derek Wallace, MBBS, vice president and global dengue program head at Takeda, discusses the impact of dengue on global health and the progress of Takeda’s dengue vaccine candidate, TAK-003, including results from the ongoing pivotal Phase 3 trial and a completed Phase 2 trial recently published in The Lancet

Dr Wallace, who has spent years working on the frontlines in dengue endemic areas, says, “It is a privilege and a thrill to work with a team of experts at Takeda Vaccines on something that has such a huge potential for public health.”


Agree or disagree with an article? Share your professional thoughts on an article you read.

Your Name
6 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Back to Top